Identification and analysis of individuals who deviate from their genetically-predicted phenotype.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
10 Feb 2023
10 Feb 2023
Historique:
entrez:
17
2
2023
pubmed:
18
2
2023
medline:
18
2
2023
Statut:
epublish
Résumé
Findings from genome-wide association studies have facilitated the generation of genetic predictors for many common human phenotypes. Stratifying individuals misaligned to a genetic predictor based on common variants may be important for follow-up studies that aim to identify alternative causal factors. Using genome-wide imputed genetic data, we aimed to classify 158,951 unrelated individuals from the UK Biobank as either concordant or deviating from two well-measured phenotypes. We first applied our methods to standing height: our primary analysis classified 244 individuals (0.15%) as misaligned to their genetically predicted height. We show that these individuals are enriched for self-reporting being shorter or taller than average at age 10, diagnosed congenital malformations, and rare loss-of-function variants in genes previously catalogued as causal for growth disorders. Secondly, we apply our methods to LDL cholesterol. We classified 156 (0.12%) individuals as misaligned to their genetically predicted LDL cholesterol and show that these individuals were enriched for both clinically actionable cardiovascular risk factors and rare genetic variants in genes previously shown to be involved in metabolic processes. Individuals whose LDL-C was higher than expected based on the genetic predictor were also at higher risk of developing coronary artery disease and type-two diabetes, even after adjustment for measured LDL-C, BMI and age, suggesting upward deviation from genetically predicted LDL-C is indicative of generally poor health. Our results remained broadly consistent when performing sensitivity analysis based on a variety of parametric and non-parametric methods to define individuals deviating from polygenic expectation. Our analyses demonstrate the potential importance of quantitatively identifying individuals for further follow-up based on deviation from genetic predictions. Human genetics is becoming increasingly useful to help predict human traits across a population owing to findings from large-scale genetic association studies and advances in the power of genetic predictors. This provides an opportunity to potentially identify individuals that deviate from genetic predictions for a common phenotype under investigation. For example, an individual may be genetically predicted to be tall, but be shorter than expected. It is potentially important to identify individuals who deviate from genetic predictions as this can facilitate further follow-up to assess likely causes. Using 158,951 unrelated individuals from the UK Biobank, with height and LDL cholesterol, as exemplar traits, we demonstrate that approximately 0.15% & 0.12% of individuals deviate from their genetically predicted phenotypes respectively. We observed these individuals to be enriched for a range of rare clinical diagnoses, as well as rare genetic factors that may be causal. Our analyses also demonstrate several methods for detecting individuals who deviate from genetic predictions that can be applied to a range of continuous human phenotypes.
Identifiants
pubmed: 36798175
doi: 10.1101/2023.02.10.528019
pmc: PMC9934696
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008924/1
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK075787
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
Nature. 2015 Jul 23;523(7561):459-462
pubmed: 26131930
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Curr Biol. 2016 Nov 21;26(22):3083-3089
pubmed: 27818178
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
Nature. 2021 Dec;600(7890):675-679
pubmed: 34887591
PLoS Genet. 2011 Dec;7(12):e1002439
pubmed: 22242009
Nature. 1991 Jul 25;352(6333):337-9
pubmed: 1852208
Nat Commun. 2020 Aug 20;11(1):3635
pubmed: 32820175
Science. 2016 Nov 11;354(6313):760-764
pubmed: 27738015
BMJ. 2008 Jun 28;336(7659):1475-82
pubmed: 18573856
Nature. 1991 Jul 25;352(6333):334-7
pubmed: 1852207
Nat Genet. 2014 Nov;46(11):1173-86
pubmed: 25282103
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Endocrinol Metab Clin North Am. 2017 Jun;46(2):259-281
pubmed: 28476223
Nature. 2022 Oct;610(7933):704-712
pubmed: 36224396
Nat Commun. 2019 Apr 16;10(1):1776
pubmed: 30992449
Stat Med. 2015 Mar 15;34(6):1041-58
pubmed: 25504555
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Nature. 2010 Oct 14;467(7317):832-8
pubmed: 20881960
Nat Genet. 2021 Jul;53(7):942-948
pubmed: 34183854
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nature. 1991 Jul 25;352(6333):330-4
pubmed: 1852206
Nat Genet. 2002 Apr;30(4):365-6
pubmed: 11896389
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Mol Psychiatry. 2021 Nov;26(11):6305-6316
pubmed: 34099873
Am J Hum Genet. 2012 Jan 13;90(1):110-8
pubmed: 22177091